Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Lustgarten Foundation Appoints Two New Board Members

The Lustgarten Foundation for Pancreatic Cancer Research
Posted on: 20 Mar 18
Lustgarten Foundation Appoints Two New Board Members

PR Newswire

WOODBURY, N.Y., March 20, 2018

WOODBURY, N.Y., March 20, 2018 /PRNewswire-USNewswire/ -- The Lustgarten Foundation announced today the appointment of two new board members – Dr. Kenneth Goodman and Ms. Willa Shalit – to its current 12-member Board of Directors. Dr. Goodman brings years of radiology and leadership experience to the role while Ms. Shalit has extensive expertise in both the for-profit and not-for-profit sectors and is the co-founder of Let's Win, an affiliate organization of the Foundation.

"We are delighted to welcome Ken and Willa to our board and look forward to their contributions," said Robert F. Vizza, Ph.D., Executive Chairman of the Lustgarten Foundation board. "As the largest private funder of pancreatic cancer research, we rely on our board for their oversight and strategic direction as we work to fulfill our mission of finding a cure for pancreatic cancer."

Ken Goodman, M.D., F.A.C.R., has been the Director of the Department of Radiology and an Attending Physician at St. Francis Hospital since 1988. Prior to his tenure at St. Francis, Dr. Goodman served as Chief of Diagnostic Radiology at the State University of New York at Stony Brook. He was also the Chief of Uroradiology at Stony Brook, and an Attending Radiologist at the Veterans Administration Medical Center in Northport, New York. Dr. Goodman is a graduate of The University of Texas Medical School at San Antonio, and trained in Diagnostic Radiology at New York Hospital - Cornell Medical Center where he completed a fellowship in Computed Tomography and Ultrasound. 

Willa Shalit is an artist, author, social entrepreneur and philanthropist, with 35 years of experience in both the for-profit and not-for-profit sectors. In 2015, Ms. Shalit co-founded Let's Win, bringing science solutions for pancreatic cancer to the general public, in conjunction with the Lustgarten Foundation. She is a co-founder and principal of RTM Limited, a consulting firm serving clients in business, finance, healthcare, environmental services and philanthropy. An author of two books, her work has been the subject of an Emmy Award-winning PBS television special and has been reported by global media including The New York Times, The International Herald Tribune, NBC, CBS, ABC, CNN, Marie Claire magazine, and O, The Oprah Magazine.

About the Lustgarten Foundation
The Lustgarten Foundation is America's largest private funder of pancreatic cancer research. Based in Woodbury, N.Y., the Foundation supports research to find a cure for pancreatic cancer, facilitates dialogue within the medical and scientific community, and educates the public about the disease through awareness campaigns and fundraising events. Since its inception, the Lustgarten Foundation has directed $154 million to research and assembled the best scientific minds with the hope that one day, a cure can be found. Thanks to separate funding to support administrative expenses, 100% of your donation goes directly to pancreatic cancer research. For more information, visit

CONTACT: Vanessa Steil, 1-516-737-1566,

View original content with multimedia:

SOURCE The Lustgarten Foundation for Pancreatic Cancer Research

PR Newswire

Last updated on: 20/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.